VICTORION-2 PREVENT

Objective

The VICTORION-2 PREVENT trial is a randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease.

National Clinical Trial (NCT) Number: 05030428

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT05030428

Research Study Categories

• Clinical Trials and Health Care Delivery Studies

Specialties

• Cardiology

Contact

Cardiology Clinical Trials at 866-839-4128, [email protected]